ARYNX | MGLRX | ARYNX / MGLRX | |
Total Expense Ratio | 0.92 | 0.85 | 108% |
Annual Report Gross Expense Ratio | 0.92 | 0.86 | 107% |
Fund Existence | 14 years | 13 years | - |
Gain YTD | 3.941 | 3.669 | 107% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 858M | 2.22B | 39% |
Annual Yield % from dividends | 2.28 | 2.59 | 88% |
Returns for 1 year | 8.07 | 2.49 | 324% |
Returns for 3 years | 14.62 | -3.83 | -382% |
Returns for 5 years | 29.36 | 14.75 | 199% |
Returns for 10 years | 53.02 | 32.52 | 163% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HRAUX | 84.64 | 0.77 | +0.92% |
Carillon Eagle Mid Cap Growth R6 | |||
VYMRX | 16.91 | 0.14 | +0.83% |
Voya Mid Cap Research Enhanced Index C | |||
GSCLX | 31.29 | 0.19 | +0.61% |
Goldman Sachs Large Cap Gr Insghts Svc | |||
GCVUX | 24.50 | 0.07 | +0.29% |
Goldman Sachs Large Cp Val Insghts R6 | |||
LHCVX | 18.65 | 0.05 | +0.27% |
Lord Abbett Health Care R6 |